Sign in to continue:

Tuesday, February 3rd, 2026

Singapore EQDP Phase II: MAS Injects S$2.85bn, Expands Asset Manager Base & SGX Opportunities in 2025

Broker Name: CGS International
Date of Report: November 19, 2025

Excerpt from CGS International report.

  • The Monetary Authority of Singapore (MAS) has appointed six more asset managers and injected an additional S\$2.85bn of liquidity into Singapore equities under the Equities Market Development Plan (EQDP), bringing total allocated funds to S\$3.95bn.
  • New initiatives include establishing cross-border partnerships such as a SGX-Nasdaq dual listing bridge and grants to support depository receipts and ETFs, with the aim of attracting quality growth companies, enhancing investor confidence, and broadening the investor base.
  • Key measures to increase demand and retail participation include reducing board lot sizes for higher-priced securities, modernising post-trade custody, and launching a S\$30m ‘value unlocking’ programme to help listed companies improve shareholder engagement and value creation.
  • The report maintains a positive outlook on SGX and highlights conviction picks such as CICT, CLAR, iFAST, KEP, SATS, SCI, and YZJSGD, noting the positive impact of increased liquidity and planned market reforms.

Report Summary:

  • MAS is injecting billions in liquidity and rolling out new initiatives to strengthen Singapore’s equities market and attract more investors.
  • The Singapore Exchange (SGX) and select big-cap stocks are expected to benefit from increased trading activity and market reforms.

Above is an excerpt from a report by CGS International. Clients of CGS International can be the first to access the full report from the CGS International website : https://www.cgsi.com.sg

Simcere Pharmaceutical (2096.HK) Shows Bullish Trend: Technical Analysis Points to Upside Potential

Trendspotter: In-Depth Analysis of Hong Kong Retail Stocks Broker Name: CGS International Securities Date of Report: December 4, 2024 Simcere Pharmaceutical Group Ltd (2096): A Bullish Outlook Simcere Pharmaceutical Group Ltd has shown a...

Coliwoo Holdings Delivers Strong FY2025 Results and Expands Co-Living Portfolio Amid Robust Singapore Market Trends

Broker Name: Lim & Tan Securities Date of Report: 27 November 2025 Excerpt from Lim & Tan Securities report. The US and global equity markets showed positive momentum, bolstered by expectations of a US...

LHN Limited & Marco Polo Marine FY2025 Results: Strong Growth, Dividends & Outlook for Singapore Stocks 1

Broker: Lim & Tan Securities Date of Report: 01 December 2025 Excerpt from Lim & Tan Securities report. The FSSTI index closed at 4,524.0, with major global indices showing mostly positive year-to-date gains; Singapore’s...